2023 ASCCP Scientific Meeting on Anogenital and HPV-Related Diseases

Claim CME - Access Here

Through an array of educational offerings, the ASCCP 2023 Scientific Meeting will bring together healthcare professionals from different backgrounds and experience levels who are interested in staying informed about the latest research dedicated to improving clinical outcomes and to reducing the burden of anogenital and HPV-related diseases around the world.

Educational Objectives:

• Integrate into practice new insights from the latest research on prevention, diagnosis and management of anogenital and HPV-related diseases.
• Describe the biology, epidemiology, natural history, and immune response to HPV, as well as the societal costs associated with HPV infections.
• Apply consensus guidelines for cervical cancer screening and management of cervical abnormalities to the general population as well as those in special circumstances.
• Apply novel screening and management strategies to underserved and under-screened individuals (transgender, incarcerated, etc.).
• Apply colposcopy to the diagnosis and management of anogenital and HPV-related diseases in ways that reflect its usefulness and maximum benefits while minimizing potential harms.
• Diagnose and treat HPV-related diseases including those that affect the cervix, vagina, vulva, anus, and head/neck. .
• Identify strategies for prevention and screening of HPV-associated oropharyngeal disorders.
• Identify novel and experimental uses of therapeutic and prophylactic HPV vaccines, including the use of “catch-up” HPV immunization.
• Apply HPV testing and relevant diagnostic tests to clinical practice in a directed, evidence-based, cost-effective manner.
• Describe the vaginal microbiome and understand its impact on HPV clearance.
• Identify the impact of implicit bias on patient care and learn techniques to identify and address this bias.
• Apply data on HPV ecology to screening and management of patients who are postmenopausal.
• Manage positive cytology and HPV test results, high risk HPV genotype results, and histologically confirmed anogenital neoplasia, reflecting current and future patient risk of high grade neoplasia.

Continuing Medical Education (CME)

ACCME Accreditation Statement
ASCCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide medical education for physicians.

Credit Designation Statement
ASCCP designates this live activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures

All those who have an opportunity to control or influence content (Faculty, Program Directors, Reviewers, Staff, etc), are required to complete a disclosure form based on the following instructions:
 
ASCCP members and the general public place great trust in the work of the Society. Real or perceived undisclosed conflicts of interest may jeopardize that trust and ASCCP’s effectiveness. Conflicts of interest also may affect the objectivity of decisions that ASCCP officers and volunteers make. To minimize the potential impact of possible conflicts of interest, the Board of Directors has determined that all participants in ASCCP activities must report all real or potential conflicts prior to the activity being developed and delivered to the learners.

Additionally, the ACCME Standards for Integrity and Independence require that we disqualify individuals who refuse to provide this information from involvement in the planning and implementation of accredited continuing education.

Please disclose all financial relationships that you have had in the past 24 months with ineligible companies (see definition below). For each financial relationship, enter the name of the ineligible company and the nature of the financial relationship(s). There is no minimum financial threshold; we ask that you disclose all financial relationships, regardless of the amount, with ineligible companies. You should disclose all financial relationships regardless of the potential relevance of each relationship to the education.

An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. For specific examples of ineligible companies visit accme.org/standards.  

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to ASCCP any financial relationship(s) that have occurred within the prior 24 months with any ineligible companies. Financial relationships are defined as remuneration in any amount from ineligible companies in the form of grants, research support, consulting fees, salary, ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds), honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors, or other financial benefits. The intent of this disclosure is not to prevent individuals with financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. ASCCP has reviewed all disclosures and mitigated all relevant financial relationships that have been identified.